QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

TNDM

QT66Tandem Diabetes Care, Inc.
NASDAQ·Healthcare·Medical - Devices·USA
Latest market price
15.30
-0.10-0.65%
OverviewShort InterestFilings
TNDMQT66Tandem Diabetes Care, Inc.·NASDAQ
OverviewShort InterestFilings
15.30-0.65%
TA
Loading chart...
Screen all →
ABT-0.10%$88.41ISRG+1.14%$406.78SYK+2.21%$307.80MDT+1.54%$79.34BSX+0.76%$45.29EW+0.78%$87.36DXCM+1.74%$72.47RMD+1.26%$188.63
Snapshot
Index-P/E-EPS (ttm)-1.40
Insider Own-
Shs Outstand-
Perf Week-3.16%
Market Cap1.06BForward P/E223.15EPS next Y0.07Insider Trans-Shs Float-Perf Month10.39%
Enterprise Value1.61BPEG-EPS next Q-0.34Inst Own-Short Float-Perf Quarter-37.88%
Income-94770248.00P/S1.03EPS this Y50.63%Inst Trans-Short Ratio-Perf Half Y-32.30%
Sales1.03BP/B7.96EPS next Y109.98%ROA-8.20%Short Interest-Perf YTD-30.39%
Book/sh-P/C53.71EPS next 5Y-ROE-68.29%52W High29.65 -48.40%Perf Year-23.77%
Cash/sh-P/FCF-EPS past 3/5Y-ROIC-8.44%52W Low9.98 53.31%Perf 3Y-
Dividend Est.-EV/EBITDA-22.40Sales past 3/5Y8.21% 15.26%Gross Margin54.93%Volatility4.30% 5.62%Perf 5Y-
Dividend TTM-EV/Sales1.57EPS Y/Y TTM25.17%Oper. Margin-7.88%ATR (14)1.27Perf 10Y-
Dividend Ex-Date-Quick Ratio3.07Sales Y/Y TTM9.26%Profit Margin-9.20%RSI (14)41.44Recom2.40
Dividend Gr. 3/5Y-Current Ratio3.58EPS Q/Q55.22%SMA20-9.31%Beta1.36Target Price31.40
Payout0.00%Debt/Eq5.55Sales Q/Q5.56%SMA50-13.24%Rel Volume1.02Prev Close15.40
Employees2,650LT Debt/Eq2.74EarningsAug 05SMA200-17.41%Avg Volume2.46MPrice15.30
IPO DateNov 14, 2013Option/ShortYes / YesEPS/Sales Surpr.34.78% 2.92%Net Debt/EBITDA-7.73Volume2,512,239Change-0.65%
Analyst Ratings
DateActionAnalystRatingTarget
Jun-01-26UpgradeWells FargoEqual Weight → Overweight$45 → $27
May-27-26ReiteratedGoldman SachsNeutral$24 → $21
May-11-26ReiteratedBarclaysOverweight$56 → $55
May-08-26ReiteratedMizuho Securities$22 → $24
Apr-24-26ReiteratedRedburn Partners$36 → $45
Mar-19-26UpgradeTruist SecuritiesHold → Buy
Mar-17-26UpgradePiper SandlerNeutral → Overweight
Feb-23-26ReiteratedTruist Financial$24 → $27
Feb-23-26ReiteratedGoldman SachsNeutral$25 → $28
Feb-23-26ReiteratedBarclaysOverweight$55 → $56
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue1,0271,015940
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A463484451
Gross Profit564531490
Selling, General and Administrative Excl. Other437434390
Research and Development188175199
Other Operating Expense2000
Operating Income-81-78-99
Interest Expense987
Unusual Expense
———
Non-Operating Income (Expense)91140
Net Income Before Taxes-98-200-92
Income Taxes-344
Consolidated Net Income-94-205-96
Net Income From Continuing Operations-94-205-96
Net Income-94-205-96
EPS (Recurring)-1.40-3.04-1.47
EPS (Basic, Before Extraordinaries)-1.40-3.04-1.47
EPS (Diluted)-1.40-3.04-1.47
EBITDA-73-175-99
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio1.011.45—
Gross Margin54.9252.3252.13
Operating Margin-7.89-7.68-10.53
Net Margin-9.15-20.20-10.21
Shares Outstanding686765
Market Capitalization1,0401,473—
Operating Lease Expense
———
Insider Trading Volume
$16.71$14.31$11.91$9.50$7.10● Close Price0.00K62.93K125.86K188.79K251.72KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Malagueira Joao Paulo FalcaoDirectorMay 21 '26Option Exercise0.0017,518022,458May 22 12:00 AM
Sodhi RajwantDirectorMay 21 '26Option Exercise0.0017,518024,280May 22 12:00 AM
TWOMEY CHRISTOPHER JDirectorMay 21 '26Option Exercise0.0017,518024,434May 22 12:00 AM
Cha MyoungilDirectorMay 21 '26Option Exercise0.0017,518022,458May 22 12:00 AM
McGroddy-Goetz KathleenDirectorMay 21 '26Option Exercise0.0017,518026,612May 22 12:00 AM
Allen Dickother: Chair EmeritusMay 21 '26Option Exercise0.0017,518028,146May 22 12:00 AM
Howell Peyton RDirectorMay 21 '26Option Exercise0.0017,518029,836May 22 12:00 AM
ROBERTSON REBECCA BDirectorMay 21 '26Option Exercise0.0017,518022,542May 22 12:00 AM
Kyrillos Jean-ClaudeEVP & Chief Operating OfficerMay 15 '26Option Exercise0.008,076029,810May 19 12:00 AM
Morrison SusanEVP & Chief Admin. OfficerMay 15 '26Option Exercise0.0019,046051,414May 19 12:00 AM
Sheridan John FPRESIDENT & CEOMay 15 '26Option Exercise0.00102,3780170,051May 19 12:00 AM
Vosseller LeighEVP & CHIEF FINANCIAL OFFICERMay 15 '26Option Exercise0.0026,990051,829May 19 12:00 AM
Novara Mark DavidEVP & CHIEF COMMERCIAL OFFICERMay 15 '26Option Exercise0.0021,144048,171May 19 12:00 AM
Carpenter RickEVP & Chief Technology OfficerMay 15 '26Option Exercise0.0017,548032,859May 19 12:00 AM
Gasser Elizabeth AnneEVP, Chief Strategy OfficerMay 15 '26Option Exercise0.0020,534015,335May 19 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR